66 / 84
66
Marie-Struempell Disease AND (methotrexate OR leflunomide
OR sulfasalazine OR gold sodium OR hydroxychloroquine OR
ciclosporin)
QUESTÃO 8: Quais são as indicações para o uso
dos agentes biológicos bloqueadores do fator de
necrose tumoral (drogas anti-TNF) na EA?
Spondylitis, Ankylosing OR Bechterew's Disease OR
Ankylosing Spondyloarthritis OR Rheumatoid Spondylitis OR
Marie-Struempell Disease AND (methotrexate OR leflunomide
OR sulfasalazine OR gold sodium OR hydroxychloroquine OR
ciclosporin)
Spondylitis, Ankylosing OR Bechterew's Disease OR
Ankylosing Spondyloarthritis OR Rheumatoid Spondylitis OR
Marie-Struempell Disease AND (Tumor Necrosis Factor-alpha
OR golimumab OR infliximab OR adalimumab OR etanercept)
QUESTÃO 9: Existe diferença de eficácia entre as
drogas anti-TNF em pacientes com EA?
Spondylitis, Ankylosing OR Bechterew's Disease OR
Ankylosing Spondyloarthritis OR Rheumatoid Spondylitis OR
Marie-Struempell Disease AND (Tumor Necrosis Factor-alpha
OR golimumab OR infliximab OR adalimumab OR etanercept)
QUESTÃO 10: Existe diferença de segurança entre
as drogas anti-TNF em pacientes com EA?